FGEN: the balance sheet

MyFinsight

For the quarter ending 2025-09-30, FGEN has $137,014K in assets. $119,529K in debts. $117,975K in cash and cash equivalents.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-09-30	2025-06-30
Cash and cash equivalents	117,975	23,367
Accounts receivable, net	121	136
Inventories	3,864	3,863
Prepaid expenses and other current assets	11,463	2,306
Current assets held for sale	0	132,650
Total current assets	133,423	162,322
Long-term investments	3,035	-
Other assets	556	839
Long-term assets held for sale	0	14,894
Total assets	137,014	178,055

Accounts payable	5,093	10,477
Accrued and other current liabilities	25,776	35,916
Senior secured term loan facilities, current	-	73,733
Deferred revenue	5,104	27,311
Current liabilities held for sale	0	8,458
Total current liabilities	35,973	155,895
Product development obligations	19,471	19,398
Deferred revenue, net of current	573	122,224
Senior secured term loan facilities, non-current	0	0
Liability related to sale of future revenues, non-current	63,414	61,306
Other long-term liabilities	98	106
Long-term liabilities held for sale	0	156
Total liabilities	119,529	359,085
Redeemable non-controlling interests	21,480	21,480
Common stock, 0.01 par value 225,000 shares authorized at september 30, 2025 and december 31, 2024 4,045 and 4,037 shares issued and outstanding at september 30, 2025 and december 31, 2024	1,011	1,011
Additional paid-in capital	1,675,999	1,673,249
Accumulated other comprehensive loss	-2,211	-4,794
Accumulated deficit	-1,691,827	-1,892,463
Total stockholders' deficit attributable to fibrogen	-17,028	-222,997
Nonredeemable non-controlling interests	13,033	20,487
Total deficit	-3,995	-202,510
Total liabilities, redeemable non-controlling interests and deficit	137,014	178,055